
Julie Zikherman MD
Assistant Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
513 Parnassus AveBox 0795San Francisco, CA 94143
Phone+1 347-268-3890
Fax+1 415-353-2640
Are you Dr. Zikherman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Julie Zikherman, MD is a rheumatologist in San Francisco, California. She is currently licensed to practice medicine in California. She is an Assistant Professor at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 2006 - 2008
- Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 2005 - 2006
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- Weill Cornell MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2006 - 2025
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.Hailyn V Nielsen, Letitia Yang, James L Mueller, Alexander J Ritter, Ryosuke Hiwa
Nature Communications. 2025-01-17 - An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens.Wei-Yun Wholey, Alexander R Meyer, Sekou-Tidiane Yoda, James L Mueller, Raisa Mathenge
Journal of Immunology. 2024-10-15 - 2 citationsTranscobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.John V Pluvinage, Thomas Ngo, Camille Fouassier, Maura McDonagh, Brandon B Holmes
Science Translational Medicine. 2024-06-26
Press Mentions
- Investigations by Leading Immune-Mediated Disease Research OrganizationsFebruary 24th, 2021
- JDRF, Lupus Research Alliance and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune DiseasesFebruary 24th, 2021
- Three UCSF Medical Students Awarded HHMI FellowshipsMay 7th, 2016
Grant Support
- Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptorsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptorsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Regulation of CD4 T cell tolerance by the NR4A family of nuclear receptorsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Academic Rheumatology and Clinical ImmunologyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Mechanisms of B cell responses to particulate antigensUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
- Nuclear Receptors in B Cell Tolerance and Humoral Immune ResponsesUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- The cell and molecular mechanisms underlying CD28 costimulationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2015–2025
- The cell and molecular mechanisms underlying CD28 costimulationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2015–2025
- The cell and molecular mechanisms underlying CD28 costimulationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2015–2025